Cognitive effects of chemotherapy in breast cancer patients: a dose-response study. (Q50559589)

15 March 2018

title

Cognitive effects of chemotherapy in breast cancer patients: a dose-response study. (English)

1 reference

15 March 2018

0 references

1 reference

Barbara Collins

1

1 reference

15 March 2018

Joyce MacKenzie

2

1 reference

15 March 2018

Giorgio A Tasca

3

1 reference

15 March 2018

Carole Scherling

4

1 reference

15 March 2018

Andra Smith

5

1 reference

15 March 2018

publication date

30 August 2012

1 reference

15 March 2018

published in

Psycho-Oncology

1 reference

15 March 2018

volume

22

1 reference

15 March 2018

issue

7

1 reference

15 March 2018

page(s)

1517-1527

1 reference

15 March 2018

Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.

cites work

1 reference

Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve

21 January 2018

1 reference

Cognitive impairment associated with adjuvant therapy in breast cancer

21 January 2018

1 reference

Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen

21 January 2018

1 reference

Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer.

21 January 2018

1 reference

Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning.

21 January 2018

1 reference

Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment.

21 January 2018

1 reference

Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide

21 January 2018

1 reference

A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients.

21 January 2018

1 reference

Prefrontal cortex and executive function impairments in primary breast cancer

21 January 2018

1 reference

Persistent neurocognitive problems after adjuvant chemotherapy for breast cancer

21 January 2018

1 reference

Cognitive speed of processing and functional declines in older cancer survivors: an analysis of data from the ACTIVE trial

21 January 2018

1 reference

The role of neuropsychological functioning in cancer survivors' return to work one year after diagnosis.

21 January 2018

1 reference

Cognitive dysfunction and subjective complaints of cancer patients. a cross-sectional study in a cancer rehabilitation centre

21 January 2018

1 reference

Cognitive impairments associated with breast cancer treatments: results from a longitudinal study

21 January 2018

1 reference

Neuropsychological functioning and quality of life during the first year after completing chemotherapy for breast cancer

21 January 2018

1 reference

Cognitive and psychological factors associated with early posttreatment functional outcomes in breast cancer survivors

21 January 2018

1 reference

Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma.

21 January 2018

1 reference

Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients

21 January 2018

1 reference

Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study

21 January 2018

1 reference

The effects of adjuvant chemotherapy on cognition in women with breast cancer--preliminary results of an observational longitudinal study.

21 January 2018

1 reference

The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study.

21 January 2018

1 reference

Cognitive Function, Fatigue, and Menopausal Symptoms in Women Receiving Adjuvant Chemotherapy for Breast Cancer

21 January 2018

1 reference

Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy.

21 January 2018

1 reference

Predictors of cognitive decline after chemotherapy in breast cancer patients.

21 January 2018

1 reference

The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial

21 January 2018

1 reference

Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer

21 January 2018

1 reference

Cognitive deficits as long-term side-effects of adjuvant therapy in breast cancer patients: 'subjective' complaints and 'objective' neuropsychological test results

21 January 2018

1 reference

Cognitive function in breast cancer patients prior to adjuvant treatment

21 January 2018

1 reference

Attention and symptom distress in women with and without breast cancer.

21 January 2018

1 reference

Prechemotherapy alterations in brain function in women with breast cancer.

21 January 2018

1 reference

Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study

21 January 2018

1 reference

Pre-chemotherapy differences in visuospatial working memory in breast cancer patients compared to controls: an FMRI study

21 January 2018

1 reference

Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors

21 January 2018

1 reference

The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study

21 January 2018

1 reference

'Chemobrain' in breast carcinoma?: a prologue

21 January 2018

1 reference

Drug delivery to tumours: recent strategies

21 January 2018

1 reference

Electrophysiological correlates of information processing in breast-cancer patients treated with adjuvant chemotherapy

21 January 2018

1 reference

Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function

21 January 2018

1 reference

Reliability and validity of a computerized neurocognitive test battery, CNS Vital Signs.

21 January 2018

1 reference

Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction

21 January 2018

1 reference

Some Tests of the Decay Theory of Immediate Memory

21 January 2018

1 reference

International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer.

21 January 2018

1 reference

Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response

21 January 2018

1 reference

Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer

21 January 2018

1 reference

Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients.

21 January 2018

1 reference

Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy

21 January 2018

1 reference

CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo.

21 January 2018

1 reference

Neurobiological basis of chemotherapy-induced cognitive impairment: a review of rodent research

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PON.3163

1 reference

15 March 2018

PubMed ID

22936651

1 reference

15 March 2018